IDO1 and Alzheimer disease: Initial research into the effects of IDO-1 inhibition in the progression of Alzheimer’s has demonstrated some efficacy in the mouse models [63], with AD-type mice demonstrating a recovery of memory in maze tests to the equivalent performance of wild-type mice, as well as a reduction in Aβ plaque burden [64].